IP Library › Assignment 074033/0629
Patent Assignment
Reel/Frame 074033/0629

Change of Name

Recorded: 2026-03-11 Pages: 6
Assignor
L&L BIOPHARMA CO., LTD.
Executed: 2025-07-25
Assignee
L&L BIO CO., LTD., NINGBO, CHINA
RM 212-26, BUILDING 1, NO.39 QIYUAN ROAD, QIANWAN NEW AREA, NINGBO, ZHEJIANG, 315336, CHINA
Covered Properties (4)
Antibody and Bispecific Antibody Targeting Lag-3 and Use Thereof
Application: 17/615,832 →
Publication: US 2022/0340657
Bispecific Antibody Targeting TIM3 and Use Thereof
Application: 17/254,862 →
Publication: US 2021/0269521
Antibody Targeting CLDN18.2, Bispecific Antibody, Adc, and Car, and Applications Thereof
Application: 17/252,259 →
Publication: US 2021/0230272
Sirpalpha-Targeting Antibody or Antigen Binding Fragment Thereof, and Preparation and Application Thereof
Application: 17/910,040 →
Publication: US 2023/0106247
Related Assignments (4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 15, 2020
From: LIU, JIAJIAN
To: L&L BIOPHARMA CO., LTD.
Reel/Frame 054643/0975 →
Assignment of Assignor's Interest Dec 2, 2021
From: LIU, JIAJIAN
To: L&L BIOPHARMA CO., LTD.
Reel/Frame 058263/0062 →
Assignment of Assignor's Interest Sep 9, 2022
From: LIU, JIAJIAN
To: L&L BIOPHARMA CO., LTD.
Reel/Frame 061037/0958 →
Assignment of Assignor's Interest Apr 2, 2026
From: LIU, JIAJIAN
To: L&L BIOPHARMA CO., LTD.
Reel/Frame 074253/0254 →